USA Bio-pharma Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Bio-pharma market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Bio-pharma market. Detailed analysis of key players, along with key growth strategies adopted by Bio-pharma industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Johnson & Johnson Services

    • Bristol-Myers Squibb Company

    • AstraZeneca PLC

    • Merck & Co, Inc

    • AbbVie

    • Bayer AG

    • Novartis AG GlaxoSmithKline Plc

    • F Hoffmann-La Roche AG

    • Abbott Laboratories

    • Sanofi, Amgen

    • Eli Lilly and Company

    • Pfizer

    • Biogen Idec

    By Type:

    • Monoclonal Antibodies

    • Recombinant Proteins

    • Granulocyte-Colony Stimulating Factor (G-CSF)

    • Interferons

    • Recombinant Human Insulin

    • Erythropoietin

    • Vaccines

    • Growth Hormones

    • Purified Proteins

    • Others

    By End-User:

    • Metabolic Disorders

    • Oncology

    • Neurological Disorders

    • Cardiovascular Diseases

    • Inflammatory and Infectious Diseases

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Bio-pharma Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Bio-pharma Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

      • 1.3.2 USA Bio-pharma Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027

      • 1.3.3 USA Bio-pharma Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) from 2016 to 2027

      • 1.3.4 USA Bio-pharma Market Size and Growth Rate of Interferons from 2016 to 2027

      • 1.3.5 USA Bio-pharma Market Size and Growth Rate of Recombinant Human Insulin from 2016 to 2027

      • 1.3.6 USA Bio-pharma Market Size and Growth Rate of Erythropoietin from 2016 to 2027

      • 1.3.7 USA Bio-pharma Market Size and Growth Rate of Vaccines from 2016 to 2027

      • 1.3.8 USA Bio-pharma Market Size and Growth Rate of Growth Hormones from 2016 to 2027

      • 1.3.9 USA Bio-pharma Market Size and Growth Rate of Purified Proteins from 2016 to 2027

      • 1.3.10 USA Bio-pharma Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Bio-pharma Market Size and Growth Rate of Metabolic Disorders from 2016 to 2027

      • 1.4.2 USA Bio-pharma Market Size and Growth Rate of Oncology from 2016 to 2027

      • 1.4.3 USA Bio-pharma Market Size and Growth Rate of Neurological Disorders from 2016 to 2027

      • 1.4.4 USA Bio-pharma Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

      • 1.4.5 USA Bio-pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases from 2016 to 2027

      • 1.4.6 USA Bio-pharma Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Bio-pharma Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Bio-pharma by Major Types

      • 3.4.1 Market Size and Growth Rate of Monoclonal Antibodies

      • 3.4.2 Market Size and Growth Rate of Recombinant Proteins

      • 3.4.3 Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF)

      • 3.4.4 Market Size and Growth Rate of Interferons

      • 3.4.5 Market Size and Growth Rate of Recombinant Human Insulin

      • 3.4.6 Market Size and Growth Rate of Erythropoietin

      • 3.4.7 Market Size and Growth Rate of Vaccines

      • 3.4.8 Market Size and Growth Rate of Growth Hormones

      • 3.4.9 Market Size and Growth Rate of Purified Proteins

      • 3.4.10 Market Size and Growth Rate of Others

    4 Segmentation of Bio-pharma Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Bio-pharma by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Bio-pharma in Metabolic Disorders

      • 4.4.2 Market Size and Growth Rate of Bio-pharma in Oncology

      • 4.4.3 Market Size and Growth Rate of Bio-pharma in Neurological Disorders

      • 4.4.4 Market Size and Growth Rate of Bio-pharma in Cardiovascular Diseases

      • 4.4.5 Market Size and Growth Rate of Bio-pharma in Inflammatory and Infectious Diseases

      • 4.4.6 Market Size and Growth Rate of Bio-pharma in Others

    5 Market Analysis by Regions

    • 5.1 USA Bio-pharma Production Analysis by Regions

    • 5.2 USA Bio-pharma Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Bio-pharma Landscape Analysis

    • 6.1 West USA Bio-pharma Landscape Analysis by Major Types

    • 6.2 West USA Bio-pharma Landscape Analysis by Major End-Users

    7 South USA Bio-pharma Landscape Analysis

    • 7.1 South USA Bio-pharma Landscape Analysis by Major Types

    • 7.2 South USA Bio-pharma Landscape Analysis by Major End-Users

    8 Middle West USA Bio-pharma Landscape Analysis

    • 8.1 Middle West USA Bio-pharma Landscape Analysis by Major Types

    • 8.2 Middle West USA Bio-pharma Landscape Analysis by Major End-Users

    9 Northeast USA Bio-pharma Landscape Analysis

    • 9.1 Northeast USA Bio-pharma Landscape Analysis by Major Types

    • 9.2 Northeast USA Bio-pharma Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Johnson & Johnson Services

        • 10.1.1 Johnson & Johnson Services Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Bristol-Myers Squibb Company

        • 10.2.1 Bristol-Myers Squibb Company Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 AstraZeneca PLC

        • 10.3.1 AstraZeneca PLC Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Merck & Co, Inc

        • 10.4.1 Merck & Co, Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 AbbVie

        • 10.5.1 AbbVie Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Bayer AG

        • 10.6.1 Bayer AG Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Novartis AG GlaxoSmithKline Plc

        • 10.7.1 Novartis AG GlaxoSmithKline Plc Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 F Hoffmann-La Roche AG

        • 10.8.1 F Hoffmann-La Roche AG Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Abbott Laboratories

        • 10.9.1 Abbott Laboratories Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Sanofi, Amgen

        • 10.10.1 Sanofi, Amgen Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Eli Lilly and Company

        • 10.11.1 Eli Lilly and Company Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Pfizer

        • 10.12.1 Pfizer Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Biogen Idec

        • 10.13.1 Biogen Idec Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Bio-pharma Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Interferons from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Recombinant Human Insulin from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Erythropoietin from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Vaccines from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Growth Hormones from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Purified Proteins from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Metabolic Disorders from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Neurological Disorders from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases from 2016 to 2027

    • Figure USA Bio-pharma Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Bio-pharma Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Bio-pharma

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Bio-pharma by Different Types from 2016 to 2027

    • Table Consumption Share of Bio-pharma by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Figure Market Size and Growth Rate of Recombinant Proteins

    • Figure Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF)

    • Figure Market Size and Growth Rate of Interferons

    • Figure Market Size and Growth Rate of Recombinant Human Insulin

    • Figure Market Size and Growth Rate of Erythropoietin

    • Figure Market Size and Growth Rate of Vaccines

    • Figure Market Size and Growth Rate of Growth Hormones

    • Figure Market Size and Growth Rate of Purified Proteins

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Bio-pharma by Different End-Users from 2016 to 2027

    • Table Consumption Share of Bio-pharma by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Metabolic Disorders

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Neurological Disorders

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Inflammatory and Infectious Diseases

    • Figure Market Size and Growth Rate of Others

    • Table USA Bio-pharma Production by Regions

    • Table USA Bio-pharma Production Share by Regions

    • Figure USA Bio-pharma Production Share by Regions in 2016

    • Figure USA Bio-pharma Production Share by Regions in 2021

    • Figure USA Bio-pharma Production Share by Regions in 2027

    • Table USA Bio-pharma Consumption by Regions

    • Table USA Bio-pharma Consumption Share by Regions

    • Figure USA Bio-pharma Consumption Share by Regions in 2016

    • Figure USA Bio-pharma Consumption Share by Regions in 2021

    • Figure USA Bio-pharma Consumption Share by Regions in 2027

    • Table West USA Bio-pharma Consumption by Types from 2016 to 2027

    • Table West USA Bio-pharma Consumption Share by Types from 2016 to 2027

    • Figure West USA Bio-pharma Consumption Share by Types in 2016

    • Figure West USA Bio-pharma Consumption Share by Types in 2021

    • Figure West USA Bio-pharma Consumption Share by Types in 2027

    • Table West USA Bio-pharma Consumption by End-Users from 2016 to 2027

    • Table West USA Bio-pharma Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Bio-pharma Consumption Share by End-Users in 2016

    • Figure West USA Bio-pharma Consumption Share by End-Users in 2021

    • Figure West USA Bio-pharma Consumption Share by End-Users in 2027

    • Table South USA Bio-pharma Consumption by Types from 2016 to 2027

    • Table South USA Bio-pharma Consumption Share by Types from 2016 to 2027

    • Figure South USA Bio-pharma Consumption Share by Types in 2016

    • Figure South USA Bio-pharma Consumption Share by Types in 2021

    • Figure South USA Bio-pharma Consumption Share by Types in 2027

    • Table South USA Bio-pharma Consumption by End-Users from 2016 to 2027

    • Table South USA Bio-pharma Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Bio-pharma Consumption Share by End-Users in 2016

    • Figure South USA Bio-pharma Consumption Share by End-Users in 2021

    • Figure South USA Bio-pharma Consumption Share by End-Users in 2027

    • Table Middle West USA Bio-pharma Consumption by Types from 2016 to 2027

    • Table Middle West USA Bio-pharma Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Bio-pharma Consumption Share by Types in 2016

    • Figure Middle West USA Bio-pharma Consumption Share by Types in 2021

    • Figure Middle West USA Bio-pharma Consumption Share by Types in 2027

    • Table Middle West USA Bio-pharma Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Bio-pharma Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Bio-pharma Consumption Share by End-Users in 2016

    • Figure Middle West USA Bio-pharma Consumption Share by End-Users in 2021

    • Figure Middle West USA Bio-pharma Consumption Share by End-Users in 2027

    • Table Northeast USA Bio-pharma Consumption by Types from 2016 to 2027

    • Table Northeast USA Bio-pharma Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Bio-pharma Consumption Share by Types in 2016

    • Figure Northeast USA Bio-pharma Consumption Share by Types in 2021

    • Figure Northeast USA Bio-pharma Consumption Share by Types in 2027

    • Table Northeast USA Bio-pharma Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Bio-pharma Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Bio-pharma Consumption Share by End-Users in 2016

    • Figure Northeast USA Bio-pharma Consumption Share by End-Users in 2021

    • Figure Northeast USA Bio-pharma Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Johnson & Johnson Services

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson Services

    • Figure Revenue and Market Share Analysis of Johnson & Johnson Services

    • Table Product and Service Introduction of Johnson & Johnson Services

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company

    • Table Company Profile and Development Status of AstraZeneca PLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC

    • Figure Sales and Growth Rate Analysis of AstraZeneca PLC

    • Figure Revenue and Market Share Analysis of AstraZeneca PLC

    • Table Product and Service Introduction of AstraZeneca PLC

    • Table Company Profile and Development Status of Merck & Co, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co, Inc

    • Figure Revenue and Market Share Analysis of Merck & Co, Inc

    • Table Product and Service Introduction of Merck & Co, Inc

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of Novartis AG GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of Novartis AG GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of Novartis AG GlaxoSmithKline Plc

    • Table Product and Service Introduction of Novartis AG GlaxoSmithKline Plc

    • Table Company Profile and Development Status of F Hoffmann-La Roche AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche AG

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche AG

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche AG

    • Table Product and Service Introduction of F Hoffmann-La Roche AG

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Sanofi, Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi, Amgen

    • Figure Sales and Growth Rate Analysis of Sanofi, Amgen

    • Figure Revenue and Market Share Analysis of Sanofi, Amgen

    • Table Product and Service Introduction of Sanofi, Amgen

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.